Developer docs
API playgroundTry for free, no card

Search company profiles

Altavo

Full company profile

uuid0002sxj

Namestring
Altavo
Legal namestring
Altavo GmbH
Websiteurl
altavo.eu
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Altavo GmbH is a medical device startup founded in 2021 in Dresden, Germany, developing a non-invasive, AI-based voice prosthesis for individuals who have lost their voice. Its primary target is patients who have undergone laryngectomy (removal of the voice box, typically following tumor surgery), with a defined secondary segment of aphonic and severely voice-impaired patients. The company employs 16 people across Dresden and Jena as of early 2026.

The core product, branded "Artificial Voice," combines non-invasive radio-frequency (RF) radar sensing with state-of-the-art deep neural networks to detect and characterize silent articulation movements in the vocal tract and convert them into natural-sounding, personalized speech in real time. The company is conducting clinical feasibility studies with five German university hospitals (University of Leipzig, University Medicine Greifswald, SRH Wald-Klinikum Gera, Municipal Hospital Dresden, and Universitätsklinikum Leipzig) and maintains technology co-development partnerships with TU Dresden's Chair of Speech Technology and Cognitive Systems and its Chair of RF and Photonics Engineering. A multi-sensor extension of the technology is being advanced through the SEMECO-B3/MUSIK consortium, co-funded by the State of Saxony and the European Union.

The business model is pre-commercial and based on future sales of a regulated medical device (hardware plus associated software/prosthetic content), with potential recurring revenue from device support and upgrades. Distribution is planned through clinical referral pathways via ENT clinics and hospital networks. The company is privately held, has raised more than €8 million across a December 2021 seed round led by High-Tech Gründerfonds, a February 2024 €5 million Series A led by OCCIDENT, and a January 2026 €3 million Series A2 co-led by Novalis Biotech and Beteiligungsmanagement Thüringen, and is preparing for commercial launch following clinical and regulatory milestones.

Short descriptiontext

Altavo is a Dresden-based medtech startup developing the Artificial Voice, a non-invasive AI-driven voice prosthesis that uses radar sensing and deep neural networks to convert silent articulation into speech for laryngectomy and other voiceless patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDresden, Germany
HQ citystring
Dresden
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
voice prosthesis devices, silent speech technology, medical speech rehabilitation, laryngectomy voice restoration, AI voice synthesis
Industry3 codes
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDAAAFAB
Text-to-Speech (TTS) & Voice Synthesis
SECONDARYEDAFAKAC
Assistive Hearing & Communication Access (Captioning, Hearing Support, Transcription)
Education/Education Technology (EdTech) & Digital Learning/Accessibility, Assistive Technology & Special Needs EdTech
NAICS code1 code
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Voice Prosthesis Medical Devices
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Artificial Voice Medical Device
TypeHardware Sales
Description

Altavo is developing a medical device (Artificial Voice) for voice rehabilitation targeting patients who have undergone laryngectomy and other voiceless individuals. Revenue is expected to be generated through the sale of medical device hardware and associated software/prosthetic products, with potential recurring revenue from device support and upgrades.

altavo.eu
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Altavo develops the Artificial Voice, an AI-based non-invasive voice prosthesis that uses radio frequency (RF) sensing technology combined with deep neural networks to detect silent articulation movements and convert them into natural-sounding speech in real time. The medical device is primarily designed for laryngectomy patients who have lost their voice due to tumor surgery, with broader applications in speech rehabilitation and human-machine interfaces.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Non-invasive voice prosthesis in development — clinical trials ongoing
+1 more record
Product overview1 text field

Altavo is an artificial voice company developing a single unified product called the Artificial Voice. This AI-based, non-invasive voice prosthesis combines state-of-the-art RF sensing technology with deep neural networks to detect silent articulation movements and convert them into audible, natural-sounding speech in real time. The product is designed primarily for laryngectomy patients who have lost their voice box due to tumor surgery, with potential applications in broader speech rehabilitation and non-medical fields.

Product and service1 record
1Artificial Voice
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Broad technology partnership with TU Dresden's Chair of Speech Technology and Cognitive Systems, combining academic expertise in speech processing with Altavo's AI and sensor technology for product development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Technology partnership with TU Dresden's Chair of Radio Frequency and Photonics Engineering supporting the development of RF sensing technology for the voice prosthesis.

3SEMECO-B3/MUSIK Consortium
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The MUSIK project is a multi-sensor non-invasive voice prosthetics initiative using AI, supported by a grant from the State of Saxony and co-funded by the European Union. Focuses on multi-sensor technology, clinical feasibility studies, antenna design, energy management, manufacturing concepts, and QM/regulatory aspects of AI-based medical devices.

altavo.eu
4University of Leipzig — Section Phoniatrics and Audiology
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical partner led by Prof. Dr. med. Michael Fuchs, providing clinical feasibility studies and patient access for the voice prosthesis development. Located at the Center of Musician Medicine and Cochlea Implant Center.

altavo.eu
5University Medicine Greifswald — Department of Phoniatrics and Pediatric Audiology
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical partner led by Dr. med. Bernhard Lehnert, Department Head of Phoniatrics and Pediatric Audiology at the ENT department, providing clinical expertise and patient cohorts for the voice prosthesis.

altavo.eu
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical partner led by Prof. Dr. med. Andreas Müller, Head of ENT/Plastic Surgery and expert in laryngology, neurolaryngology, and laryngeal pacing, providing specialized clinical input for laryngectomy patients.

7Municipal Hospital Dresden — Department of ENT, Head and Neck Surgery
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical partner led by Prof. Dr. med. Friedemann Pabst, also affiliated with the laboratory for voice research at Dresden College of Music, combining clinical and musicology expertise for voice rehabilitation.

altavo.eu
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Clinical partner represented by Ulrike Sievert, Clinical Speech Scientist, providing speech science expertise and patient interaction capabilities.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

InHealth Technologies manufactures and distributes tracheoesophageal voice prostheses and related consumables for laryngectomy patients, directly competing with Altavo's target user population through clinical channels and ENT specialists.

TypeDirect peer
Description

German manufacturer of voice prostheses, tracheostomy tubes, and heat-and-moisture exchangers for laryngectomy patients. Direct competitor in the DACH region across the same clinical specialty and customer base.

TypeEmerging player
Description

SpeechAgain applies AI and acoustic analysis to speech therapy and rehabilitation, addressing stuttering and similar disorders. Adjacent to Altavo's broader speech rehabilitation thesis beyond laryngectomy.

TypeEmerging player
Description

Naqi Logix develops a discreet neural earbud that translates subtle facial and jaw microgestures into commands. Comparable as a silent-speech / human-machine interface technology player with potential medtech adjacency.

5Servona GmbH
TypeDirect peer
Description

Servona develops and supplies voice prostheses, tracheostomy tubes, and laryngectomy care products in Germany and Europe. As a regional incumbent in the same clinical specialty, it competes with Altavo for ENT clinic relationships and laryngectomy patient referrals.

TypeEmerging player
Description

Dutch AI voice-tech startup that converts whispered and impaired speech into clear, natural-sounding voice in real time. Comparable in applying AI to voice-restoration use cases, though Altavo additionally addresses the laryngectomy cohort via non-audio sensing.

7Sonospeech (ETH Zurich spin-off)
TypeEmerging player
Description

ETH Zurich spin-off developing silent-speech interface technology via ultrasound imaging of the tongue. Comparable as an academic-spin-out silent-speech platform targeting hands-free and accessibility applications.

TypeBroad incumbent
Description

OpenAI develops large-scale speech synthesis and generative voice AI (e.g., Voice Engine, TTS APIs). Comparable as a broad incumbent whose rapidly advancing speech synthesis models underpin the AI component of Altavo's offering and could eventually be integrated or commoditized.

TypeEmerging player
Description

VocaliD pioneered personalized AI voice creation for users who have lost or never had a voice. Comparable as an AI-driven personalized voice platform, though its delivery model is digital voice rather than a non-invasive hardware prosthesis.

TypeDirect peer
Description

Atos Medical is the global market leader in laryngectomy voice and pulmonary rehabilitation, acquired by Coloplast in 2021. It sells the Provox tracheoesophageal voice prosthesis range — the incumbent non-invasive-but-surgical solution Altavo is positioning against.

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Altavo

Voice Prosthesis Medical Devicesaltavo.eu

Altavo is a Dresden-based medtech startup developing the Artificial Voice, a non-invasive AI-driven voice prosthesis that uses radar sensing and deep neural networks to convert silent articulation into speech for laryngectomy and other voiceless patients.

What Altavo does

Altavo GmbH is a medical device startup founded in 2021 in Dresden, Germany, developing a non-invasive, AI-based voice prosthesis for individuals who have lost their voice. Its primary target is patients who have undergone laryngectomy (removal of the voice box, typically following tumor surgery), with a defined secondary segment of aphonic and severely voice-impaired patients. The company employs 16 people across Dresden and Jena as of early 2026.

The core product, branded "Artificial Voice," combines non-invasive radio-frequency (RF) radar sensing with state-of-the-art deep neural networks to detect and characterize silent articulation movements in the vocal tract and convert them into natural-sounding, personalized speech in real time. The company is conducting clinical feasibility studies with five German university hospitals (University of Leipzig, University Medicine Greifswald, SRH Wald-Klinikum Gera, Municipal Hospital Dresden, and Universitätsklinikum Leipzig) and maintains technology co-development partnerships with TU Dresden's Chair of Speech Technology and Cognitive Systems and its Chair of RF and Photonics Engineering. A multi-sensor extension of the technology is being advanced through the SEMECO-B3/MUSIK consortium, co-funded by the State of Saxony and the European Union.

The business model is pre-commercial and based on future sales of a regulated medical device (hardware plus associated software/prosthetic content), with potential recurring revenue from device support and upgrades. Distribution is planned through clinical referral pathways via ENT clinics and hospital networks. The company is privately held, has raised more than €8 million across a December 2021 seed round led by High-Tech Gründerfonds, a February 2024 €5 million Series A led by OCCIDENT, and a January 2026 €3 million Series A2 co-led by Novalis Biotech and Beteiligungsmanagement Thüringen, and is preparing for commercial launch following clinical and regulatory milestones.

Altavo firmographics

Firmographics
Name
Altavo
Legal name
Altavo GmbH
Website
https://altavo.eu
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
Altavo is a Dresden-based medtech startup developing the Artificial Voice, a non-invasive AI-driven voice prosthesis that uses radar sensing and deep neural networks to convert silent articulation into speech for laryngectomy and other voiceless patients.
Ownership category
akta.pro rank

Altavo industry classification

Industry
Product category
Voice Prosthesis Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDAAAFAB
Text-to-Speech (TTS) & Voice Synthesis
SECONDARYEDAFAKAC
Assistive Hearing & Communication Access (Captioning, Hearing Support, Transcription)
Education/Education Technology (EdTech) & Digital Learning/Accessibility, Assistive Technology & Special Needs EdTech

Keywords

  • Voice prosthesis devices
  • Silent speech technology
  • Medical speech rehabilitation
  • Laryngectomy voice restoration
  • AI voice synthesis

Where Altavo is headquartered

Location

Headquarters

HQ city
Dresden
HQ country
Germany
HQ region
Europe

Offices3 records

Markets served

Altavo business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Artificial Voice Medical Device: Altavo is developing a medical device (Artificial Voice) for voice rehabilitation targeting patients who have undergone laryngectomy and other voiceless individuals. Revenue is expected to be generated through the sale of medical device hardware and associated software/prosthetic products, with potential recurring revenue from device support and upgrades.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Altavo product offering

Product offering

Core offering

Altavo develops the Artificial Voice, an AI-based non-invasive voice prosthesis that uses radio frequency (RF) sensing technology combined with deep neural networks to detect silent articulation movements and convert them into natural-sounding speech in real time. The medical device is primarily designed for laryngectomy patients who have lost their voice due to tumor surgery, with broader applications in speech rehabilitation and human-machine interfaces.

Product overview

Altavo is an artificial voice company developing a single unified product called the Artificial Voice. This AI-based, non-invasive voice prosthesis combines state-of-the-art RF sensing technology with deep neural networks to detect silent articulation movements and convert them into audible, natural-sounding speech in real time. The product is designed primarily for laryngectomy patients who have lost their voice box due to tumor surgery, with potential applications in broader speech rehabilitation and non-medical fields.

Differentiator

Problem solved

Functional benefit

Products and services

  • Artificial Voice

Quantifiable outcome

  • Non-invasive voice prosthesis in development — clinical trials ongoing
  • +1 more outcomes

Companies that use Altavo

Customer profile

Segments2 records

Ideal customer profiles2 records

Altavo technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

Altavo partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and supporting.

  • TU Dresden — Chair of Speech Technology and Cognitive SystemscoreStrategic or Co-development PartnerBroad technology partnership with TU Dresden's Chair of Speech Technology and Cognitive Systems, combining academic expertise in speech processing with Altavo's AI and sensor technology for product development.
  • TU Dresden — Chair of Radio Frequency and Photonics EngineeringcoreStrategic or Co-development PartnerTechnology partnership with TU Dresden's Chair of Radio Frequency and Photonics Engineering supporting the development of RF sensing technology for the voice prosthesis.
  • SEMECO-B3/MUSIK ConsortiumcoreStrategic or Co-development PartnerThe MUSIK project is a multi-sensor non-invasive voice prosthetics initiative using AI, supported by a grant from the State of Saxony and co-funded by the European Union. Focuses on multi-sensor technology, clinical feasibility studies, antenna design, energy management, manufacturing concepts, and QM/regulatory aspects of AI-based medical devices.
  • University of Leipzig — Section Phoniatrics and AudiologycoreStrategic or Co-development PartnerClinical partner led by Prof. Dr. med. Michael Fuchs, providing clinical feasibility studies and patient access for the voice prosthesis development. Located at the Center of Musician Medicine and Cochlea Implant Center.
  • University Medicine Greifswald — Department of Phoniatrics and Pediatric AudiologycoreStrategic or Co-development PartnerClinical partner led by Dr. med. Bernhard Lehnert, Department Head of Phoniatrics and Pediatric Audiology at the ENT department, providing clinical expertise and patient cohorts for the voice prosthesis.
  • SRH Wald-Klinikum GeracoreStrategic or Co-development PartnerClinical partner led by Prof. Dr. med. Andreas Müller, Head of ENT/Plastic Surgery and expert in laryngology, neurolaryngology, and laryngeal pacing, providing specialized clinical input for laryngectomy patients.
  • Municipal Hospital Dresden — Department of ENT, Head and Neck SurgerycoreStrategic or Co-development PartnerClinical partner led by Prof. Dr. med. Friedemann Pabst, also affiliated with the laboratory for voice research at Dresden College of Music, combining clinical and musicology expertise for voice rehabilitation.
  • Universitätsklinikum Leipzig — Clinical Speech ScientistsupportingStrategic or Co-development PartnerClinical partner represented by Ulrike Sievert, Clinical Speech Scientist, providing speech science expertise and patient interaction capabilities.

Scale indicators3 records

Recent moves6 records

Expansion highlights7 records

Altavo competitors and assessment

Company assessment

Direct peers

  • InHealth Technologies: InHealth Technologies manufactures and distributes tracheoesophageal voice prostheses and related consumables for laryngectomy patients, directly competing with Altavo's target user population through clinical channels and ENT specialists.
  • Andreas Fahl Medizintechnik: German manufacturer of voice prostheses, tracheostomy tubes, and heat-and-moisture exchangers for laryngectomy patients. Direct competitor in the DACH region across the same clinical specialty and customer base.
  • Servona GmbH: Servona develops and supplies voice prostheses, tracheostomy tubes, and laryngectomy care products in Germany and Europe. As a regional incumbent in the same clinical specialty, it competes with Altavo for ENT clinic relationships and laryngectomy patient referrals.
  • Atos Medical (Coloplast): Atos Medical is the global market leader in laryngectomy voice and pulmonary rehabilitation, acquired by Coloplast in 2021. It sells the Provox tracheoesophageal voice prosthesis range — the incumbent non-invasive-but-surgical solution Altavo is positioning against.

Emerging players

  • SpeechAgain: SpeechAgain applies AI and acoustic analysis to speech therapy and rehabilitation, addressing stuttering and similar disorders. Adjacent to Altavo's broader speech rehabilitation thesis beyond laryngectomy.
  • Naqi Logix: Naqi Logix develops a discreet neural earbud that translates subtle facial and jaw microgestures into commands. Comparable as a silent-speech / human-machine interface technology player with potential medtech adjacency.
  • Whispp: Dutch AI voice-tech startup that converts whispered and impaired speech into clear, natural-sounding voice in real time. Comparable in applying AI to voice-restoration use cases, though Altavo additionally addresses the laryngectomy cohort via non-audio sensing.
  • Sonospeech (ETH Zurich spin-off): ETH Zurich spin-off developing silent-speech interface technology via ultrasound imaging of the tongue. Comparable as an academic-spin-out silent-speech platform targeting hands-free and accessibility applications.
  • VocaliD (Veritone Voice): VocaliD pioneered personalized AI voice creation for users who have lost or never had a voice. Comparable as an AI-driven personalized voice platform, though its delivery model is digital voice rather than a non-invasive hardware prosthesis.

Broad incumbents

  • OpenAI: OpenAI develops large-scale speech synthesis and generative voice AI (e.g., Voice Engine, TTS APIs). Comparable as a broad incumbent whose rapidly advancing speech synthesis models underpin the AI component of Altavo's offering and could eventually be integrated or commoditized.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Altavo financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Altavo leadership team

Management profile

Number of profiles

Profiles15 records

Altavo funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Altavo M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Altavo

What does Altavo do?

Altavo develops the Artificial Voice, an AI-based non-invasive voice prosthesis that uses radio frequency (RF) sensing technology combined with deep neural networks to detect silent articulation movements and convert them into natural-sounding speech in real time. The medical device is primarily designed for laryngectomy patients who have lost their voice due to tumor surgery, with broader applications in speech rehabilitation and human-machine interfaces.

Is Altavo a public or private company?

Altavo is a private company. It is classified as venture growth investor backed and is currently operating.

When was Altavo founded?

Altavo was founded in 2021. It employs 11 to 50 people.

Where is Altavo based?

Altavo is headquartered in Dresden, Germany, in the Europe region.

How does Altavo make money?

One revenue line is on record: artificial Voice Medical Device.

Who are Altavo's main competitors?

Direct peers on record are InHealth Technologies, Andreas Fahl Medizintechnik, Servona GmbH and Atos Medical (Coloplast). Emerging players are SpeechAgain, Naqi Logix, Whispp, Sonospeech (ETH Zurich spin-off) and VocaliD (Veritone Voice). OpenAI is listed as a broad incumbent.

Does Altavo have an API?

No public API is recorded for Altavo.

What industry is Altavo in?

Altavo's product category is Voice Prosthesis Medical Devices. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HDAAAFAB, Text-to-Speech (TTS) & Voice Synthesis. Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PRLogeasyGDS Becomes altovo as Travel Commerce Platform Outgrows Original NameeasyGDS has rebranded as altovo, effective July 1, 2026, after five years of evolution from a GDS connection tool to a full travel commerce platform. The Dubai-based company now serves airlines, loyalty programmes, retailers, and corporate buyers, with existing agreements and infrastructure unchanged.FinSMEsAltavo Closes €3M Series A2 Financing RoundAltavo, a Dresden, Germany-based medtech startup specializing in AI-based voice rehabilitation for aphonic and severely voice-impaired patients, has closed a €3 million Series A2 financing round. The round was led by Novalis Biotech and Beteiligungsmanagement Thüringen, with participation from multiple regional investment funds. The company plans to use the proceeds to advance clinical work and develop its commercial product, currently employing 16 people across its Dresden and Jena locations.HighAltavo concludes Series A2 for the development of its Artificial VoiceAltavo, a Dresden-based medtech startup developing AI-based voice rehabilitation technology, successfully closed a Series A2 financing round on January 12, 2026, raising €3 million from a European investor consortium. The funding round was co-led by Novalis Biotech and Beteiligungsmanagement Thüringen, with participation from TGFS Technologiegründerfonds Sachsen, High-Tech Gründerfonds, TUDAG TU Dresden AG, Ostwerk GmbH, and individual private investors. The capital will support company development, clinical work, and the commercial development of Altavo's Artificial Voice product, which uses non-invasive radar sensing and AI algorithms to help voiceless patients regain natural-sounding speech.NovalAltavo concludes Series A for the development of its Artificial VoiceAltavo, an AI-based voice rehabilitation startup, closed its Series A financing round on February 1, 2024, raising €5.0 million led by OCCIDENT. The funds will support product development, a pivotal clinical trial for its Artificial Voice medical device, and international expansion. This investment follows collaboration with the Technical University Dresden and participation from other investors including Novalis Biotech and German regional funds.FinSMEsAltavo Closes €5M Series A FundingAltavo, an AI-based voice rehabilitation company based in Germany, has closed a €5 million Series A funding round led by Occident with participation from several other investors. The company plans to utilize these funds to accelerate product development, conduct pivotal clinical trials for its Artificial Voice medical device, and expand internationally.StartbaseAltavo closes seed financing roundAltavo, a voice prosthesis start-up and spin-off from TU Dresden, has completed its seed financing round with investments from High-Tech Gründerfonds, Technologiegründerfonds Sachsen, Saxonia Systems Holding GmbH, and TUDAG TU Dresden AG. The company intends to use the undisclosed capital for development phases and upcoming clinical pilot studies for its AI-driven device designed to help voiceless patients regain natural speech.